United Capital Financial Advisors’s Core Laboratories CLB Stock Holding History

United Capital Financial Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,744	Closed	-$220K	–	1339
2018 Q2	$220K	Buy	+1,744	New	+$212K	﹤0.01%	1199
2015 Q1	–	Sell	-1,852	Closed	-$223K	–	1239
2014 Q4	$223K	Sell	1,852 -38	-2%	-$4.99K	﹤0.01%	1060
2014 Q3	$277K	Buy	+1,890	New	+$292K	﹤0.01%	953
2014 Q2	–	Sell	-2,700	Closed	-$536K	–	810
2014 Q1	$536K	Buy	2,700 +1,370	+103%	+$259K	0.01%	621
2013 Q4	$254K	Sell	1,330 -608	-31%	-$113K	0.01%	563
2013 Q3	$328K	Buy	+1,938	New	+$301K	0.01%	539

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Royal London Asset Management United Kingdom $54.3B AUM 39.21% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

United Capital Financial Advisors's CLB Position: Q3 2018 in Review

United Capital Financial Advisors sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 1,744 shares — an estimated $220K sold.

United Capital Financial Advisors first reported a position in CLB in Q3 2013 and held it in 6 quarters. The position peaked at $536K in Q1 2014. 359 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

United Capital Financial Advisors reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
United Capital Financial Advisors sold 1,744 Core Laboratories shares in Q3 2018, an estimated $220K.
United Capital Financial Advisors first reported a position in Core Laboratories in Q3 2013 and held it in 6 quarters.
United Capital Financial Advisors's Core Laboratories position peaked at $536K in Q1 2014.
359 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on United Capital Financial Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.